Liza Levy is Co-Founder and Chief Commercial Officer at Unravel Health, a London-based femtech startup pioneering daily at-home hormone monitoring through its palm-sized Micro Lab device that reads multiple hormones from a saliva sample in minutes.

Liza earned an MA in Chinese from the University of Edinburgh and an MBA from INSEAD, where she won First Prize in the Business Venture Competition and the Women in Entrepreneurship Award, taking home a combined prize of EUR 15,000 in startup capital.

A multilingual entrepreneur fluent in English, Spanish, Hebrew, and Chinese, Liza brings a rare blend of commercial acumen and global perspective to closing the data gap in women's hormonal health.

Liza co-founded Unravel Health in 2024 alongside CEO Veronika Bridgman and CMO Dr. Alexandra Oti, and has driven partnerships including a collaboration with Hospital Privado de Comunidad in Argentina to advance hormone research.

Unravel Health has raised EUR 2.96 million in Seed funding led by Conduit EIS Impact Fund and Wrightwood, building on over EUR 1.18 million in prior grants from Innovate UK, the Medical Research Council, and SBRI, with its technology underpinned by three granted patents.